Cargando…

LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker

The traditional approach to the management of coronary artery disease (CAD) focuses mainly on low density lipoprotein cholesterol (LDL-C) which is often considered a crucial risk factor for the progression of atherosclerosis. Despite its extensive use in predicting CAD risk, it has become a sub-opti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aggarwal, Dr Jyoti, Kathariya, Mr Gobardhan, Verma, Dr Puneet K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514398/ https://www.ncbi.nlm.nih.gov/pubmed/34627566 http://dx.doi.org/10.1016/j.ihj.2021.07.013

Ejemplares similares

Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences
por: Kathariya, Gobardhan, et al.
Publicado: (2020)

LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone
por: Enomoto, Mika, et al.
Publicado: (2011)

ApoD Mediates Binding of HDL to LDL and to Growing T24 Carcinoma
por: Braesch-Andersen, Sten, et al.
Publicado: (2014)

Trends in LDL-C and Non-HDL-C Levels with Age
por: Zhang, Peng, et al.
Publicado: (2020)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
por: León-Reyes, G., et al.
Publicado: (2018)

Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19
por: Mohammadshahi, Jafar, et al.
Publicado: (2023)

The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population
por: Xiao, Li, et al.
Publicado: (2023)

Markers of Increased Cardiovascular Risk in Postmenopausal Women: Focus on Oxidized-LDL and HDL Subpopulations
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials
por: Thanassoulis, George, et al.
Publicado: (2014)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State
por: Miida, Takashi, et al.
Publicado: (2017)

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
por: Masson, Walter, et al.
Publicado: (2015)

The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C
por: Jung, Hae Won, et al.
Publicado: (2023)

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
por: Liao, Fangxin, et al.
Publicado: (2015)

Which one of LDL-C /HDL-C ratio and non-HDL-C can better predict the severity of coronary artery disease in STEMI patients
por: Gao, Po, et al.
Publicado: (2022)

A Western-Fed Diet Increases Plasma HDL and LDL-Cholesterol Levels in ApoD–/– Mice
por: Ali, Kamilah, et al.
Publicado: (2014)

Combining LDL-C and HDL-C to predict survival in late life: The InChianti study
por: Zuliani, Giovanni, et al.
Publicado: (2017)

Serum LDL-C/HDL-C ratio and the risk of carotid plaques: a longitudinal study
por: Wu, Zhuchao, et al.
Publicado: (2022)

Friedewald formula may be used to calculate non-HDL-C from LDL-C and TG
por: Romaszko, Jerzy, et al.
Publicado: (2023)

Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population: Analysis of an array of lipid metrics in an AWI-Gen sub-study
por: Agongo, Godfred, et al.
Publicado: (2022)

Sex differences in HDL ApoC-III in American Indian youth
por: Blackett, Piers R, et al.
Publicado: (2012)

Triglyceride and non-HDL-C are better predictors of cardiovascular disease risk factors in Chinese Han children and adolescents than LDL-C
por: Zhu, Wei-fen, et al.
Publicado: (2013)

Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang, China
por: Chen, Qing-Jie, et al.
Publicado: (2016)

Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: A marker of atherogenic heterogeneity
por: Razavi, Alexander C., et al.
Publicado: (2021)

The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study
por: Qin, Guangming, et al.
Publicado: (2015)

HDL-C/LDL-C and Risk of Cerebral White Matter Hyperintensities: A Cross-Sectional Study
por: Wei, Cunsheng, et al.
Publicado: (2023)

Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination
por: Hernáez, Álvaro, et al.
Publicado: (2019)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

Associação Positiva entre Autoanticorpos contra LDL Oxidada e HDL-C: Um Novo Mecanismo para Cardioproteção de HDL?
por: Nunez, Carla Evelyn Coimbra, et al.
Publicado: (2022)

The ideal marker for measuring GFR: what are we looking for?
por: Claudio, Maioli, et al.
Publicado: (2020)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk
por: Kuang, YaShu, et al.
Publicado: (2016)

High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients
por: Chan, L.W., et al.
Publicado: (2014)

Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials
por: Qiu, Chengfeng, et al.
Publicado: (2019)

Caryocar brasiliense Cambess. Pulp Oil Supplementation Reduces Total Cholesterol, LDL-c, and Non-HDL-c in Animals
por: Torres Silva, Gabriela, et al.
Publicado: (2020)

Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines
por: Quispe, Renato, et al.
Publicado: (2021)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i8r1ask7rvucpkk9s25vu1le1s